Determining KOL Status
for FMV
KOL (Key Opinion Leader), or thought leader, tiering frameworks are widely used by pharmaceutical and medical device companies to differentiate healthcare professionals (HCPs) based on perceived levels of expertise. These tiering models—often referred to as KOL tiering, HCP tiering, or FMV tiering—are frequently used to support the application of higher Fair Market Value (FMV) rates for individuals classified at more advanced tiers. However, many of these frameworks rely on structural assumptions that can result in an inaccurate assessment of expertise. Where this occurs, the resulting tier designations may not provide a reliable or defensible basis for applying premium FMV compensation.
Why KOL Tiering Directly Impacts FMV
FMV measures only the market value of different types and levels of medical expertise. KOL tiering models serve as the mechanism by which companies determine which HCPs warrant premium compensation. When those models contain structural limitations, they can produce an inaccurate picture of an HCP’s expertise. The result is not simply a classification issue, but a downstream FMV risk: if KOL status is inaccurately assigned, the premium rates justified by that status may not reflect the actual level of expertise.
Limitations of Common KOL Tiering Approaches
Points-Based Approaches to KOL Tiering
Evaluation models based on point systems currently dominate the KOL assessment landscape. Under these frameworks, KOL status is determined by the cumulative number of points associated with specific criteria or by the number of checklist criteria an HCP satisfies. These models are easy to create and implement, but their structure introduces limitations that increase the likelihood of overpayment.
Breadth of Recognition Bias
Points-based models tend to favor HCPs who participate in a broad range of professional activities. Physicians with moderate levels of expertise across many categories can accumulate points more easily than those who focus deeply in fewer areas. As a result, an HCP with average expertise across multiple categories may achieve national KOL status by amassing sufficient points, creating a clear risk of over-tiering and overpayment.
Conversely, these models can undervalue physicians who concentrate their efforts in a smaller number of domains. High levels of achievement in research or publication, for example, may not be fully reflected if the model also rewards participation in leadership roles or other activities that are not essential to demonstrating expertise. Differences in career paths, such as academic versus clinical focus, may also not be adequately captured, further distorting the assessment.
Selection Versus Expertise Bias
A second limitation arises when KOL models incorporate criteria that measure relevance to a company’s business rather than an HCP’s medical expertise, effectively elevating activity relevance over objective measures of expertise. Criteria such as participation in company registration trials, familiarity with company products, or experience in a narrowly defined research area may be useful when selecting HCPs for specific engagements, but they do not measure the level of expertise itself.
While these considerations may be appropriate when identifying candidates for speaker or consulting programs, they are not a measure of expertise and should not be used to justify premium FMV rates. An HCP may be highly knowledgeable in a company-relevant niche but not recognized as having broader expertise within the field. In these cases, the distinction is critical: FMV should reflect broader recognition of expertise, not alignment with a company’s immediate needs.
Where companies must engage a non-KOL specialist for a particular service and pay a premium as a result, this is better understood as an FMV exception rather than a basis for assigning a higher KOL tier.
Subjectivity Bias
KOL evaluation models often include criteria that are conceptually relevant but difficult to measure objectively. This creates opportunities for subjective interpretation and inconsistent application. Broad terms such as “recognized,” “extensive,” “frequent,” or “leading” can carry different meanings for different reviewers, leading to variation in scoring outcomes.
Authorship provides a clear example. Two HCPs with similar publication records may receive different scores depending on how reviewers interpret what constitutes an “extensive” record. This lack of specificity can result in over-tiering and, ultimately, overpayment.
Characteristics of a More Effective Evaluation Model
More effective KOL evaluation models are grounded in objective, peer-recognition-based criteria. KOL status should be grounded in the judgment of an HCP’s peers rather than in the opinions of the company or individual reviewer. This provides a more objective and independent foundation for evaluation and reduces the influence of company-driven selection factors.
These models also rely on quantifiable, clearly documented criteria derived primarily from CVs. Clear documentation supports consistency in application and provides transparency, creating a defensible record of how determinations were made.
Finally, effective models maintain flexibility. Rather than relying on cumulative point totals, which can overvalue breadth of activity, models should emphasize a limited number of evaluation categories with rigorous standards set within each. This approach allows for recognition of different professional paths and supports accurate evaluation even when only partial information is available.
Implications for KOL Designation and FMV
KOL designation serves as the basis for determining when premium compensation is appropriate. As a result, the process used to assign KOL status functions as a gatekeeper for the application of higher FMV rates tied to elevated levels of expertise. When KOL status is determined using evaluation models that emphasize company-specific relevance or rely on subjective interpretation, the resulting classifications may not reflect true differences in medical expertise and can weaken the justification for paying premium FMV rates.
More reliable approaches distinguish clearly between indicators of expertise and factors related to company selection needs, relying on criteria that reflect how physicians are recognized within their field, applying those criteria consistently, and allowing for variation in how expertise is developed and demonstrated. Where KOL designation is grounded in these principles, it provides a more defensible basis for differentiating levels of expertise and supporting the application of premium FMV rates; where it is not, the resulting classifications may be difficult to support and increase the risk of overpayment.
About This Publication
This article is based on prior published work in RX Compliance Report, a publication focused on pharmaceutical sales and marketing compliance.
To request a copy of the original publication, please use the button below.